Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/185237
Title: | Ethical implications of epigenetics in the era of personalized medicine |
Author: | Santaló, Josep Berdasco, María |
Keywords: | Epigenètica Ètica mèdica Bioètica Epigenetics Medical ethics Bioethics |
Issue Date: | 25-Mar-2022 |
Publisher: | Springer Science and Business Media LLC |
Abstract: | Given the increasing research activity on epigenetics to monitor human diseases and its connection with lifestyle and environmental expositions, the field of epigenetics has attracted a great deal of interest also at the ethical and societal level. In this review, we will identify and discuss current ethical, legal and social issues of epigenetics research in the context of personalized medicine. The review covers ethical aspects such as how epigenetic information should impact patient autonomy and the ability to generate an intentional and voluntary decision, the measures of data protection related to privacy and confidentiality derived from epigenome studies (e.g., risk of discrimination, patient re-identification and unexpected findings) or the debate in the distribution of responsibilities for health (i.e., personal versus public responsibilities). We pay special attention to the risk of social discrimination and stigmatization as a consequence of inferring information related to lifestyle and environmental exposures potentially contained in epigenetic data. Furthermore, as exposures to the environment and individual habits do not affect all populations equally, the violation of the principle of distributive justice in the access to the benefits of clinical epigenetics is discussed. In this regard, epigenetics represents a great opportunity for the integration of public policy measures aimed to create healthier living environments. Whether these public policies will coexist or, in contrast, compete with strategies reinforcing the personalized medicine interventions needs to be considered. The review ends with a reflection on the main challenges in epigenetic research, some of them in a technical dimension (e.g., assessing causality or establishing reference epigenomes) but also in the ethical and social sphere (e.g., risk to add an epigenetic determinism on top of the current genetic one). In sum, integration into life science investigation of social experiences such as exposure to risk, nutritional habits, prejudice and stigma, is imperative to understand epigenetic variation in disease. This pragmatic approach is required to locate clinical epigenetics out of the experimental laboratories and facilitate its implementation into society. |
Note: | Reproducció del document publicat a: https://doi.org/10.1186/s13148-022-01263-1 |
It is part of: | Clinical Epigenetics, 2022, vol. 14, num. 44 |
URI: | http://hdl.handle.net/2445/185237 |
Related resource: | https://doi.org/10.1186/s13148-022-01263-1 |
Appears in Collections: | Publicacions de projectes de recerca finançats per la UE Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s13148-022-01263-1.pdf | 1.15 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License